HCC criteria for liver transplantation: Controversies
Citations Over Time
Abstract
Key Points: 1 Liver transplantation (LT) is considered to be the first-line treatment option for patients with hepatocellular carcinoma (HCC) within Milan criteria not suitable for resection. 2 Extension of tumor limit criteria has not been well established. Modest expansion of Milan criteria applying the “up-to-7” in patients without macrovascular invasion achieves competitive outcomes. 3 Neoadjuvant treatment can be considered before LT (downstaging). 4 After LT, an immunosuppressive regimen containing calcineurin inhibitors has been associated in a dose-dependent fashion with an increased risk of posttransplant HCC recurrence, whereas promising results come from the use of mammalian target of rapamycin inhibitor. 5 Further studies are needed to guarantee allocation equity between patients with and patients without HCC who are waiting for LT.
Related Papers
- Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey.(2003)
- Spontaneous rupture of hepatocellular carcinoma.(2002)
- Pathology of hepatocellular carcinoma(2006)
- The medical management of hepatocellular carcinoma (HCC) in Japan: a review with implications for HCC seen in the west.(1997)
- Analysis of the influence factors of serum alpha-fetoprotein levels in patients with hepatocellular carcinoma(2001)